Advanced search
Publication Cover
International Journal of Neuroscience Volume 121, 2011 - Issue 10
Submit an article Journal homepage
309
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of Serum IgG Subclass Concentrations in Myasthenia Gravis Patients

Yudong Liu;National Center for Clinical Laboratories, Beijing Hospital, Beijing, China
,
Wei Wang;Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
&
Jinming Li;National Center for Clinical Laboratories, Beijing Hospital, Beijing, ChinaCorrespondence[email protected]
Pages 570-574 | Received 27 Dec 2010, Accepted 05 Jun 2011, Published online: 19 Jul 2011

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Renato Mantegazza & Paola Cavalcante. (2020) Eculizumab for the treatment of myasthenia gravis. Expert Opinion on Biological Therapy 20:9, pages 991-998.
Read now

Articles from other publishers (11)

Dana L.E. Vergoossen, Annabel M. Ruiter, Kevin R. Keene, Erik H. Niks, Martijn R. Tannemaat, Ellen Strijbos, Alexander F. Lipka, Els C. Jol van der Zijde, Maarten J.D. van Tol, Jaap A. Bakker, Brigitte A. Wevers, Elisabet Westerberg, Lúcia S. Borges, Olivia C. Tong, David P. Richman, Isabel Illa, Anna Rostedt Punga, Amelia Evoli, Silvère M. van der Maarel, Jan J. Verschuuren & Maartje G. Huijbers. (2022) Enrichment of serum IgG4 in MuSK myasthenia gravis patients. Journal of Neuroimmunology 373, pages 577978.
Crossref
Nicola Iacomino, Fiammetta Vanoli, Rita Frangiamore, Marta Ballardini, Letizia Scandiffio, Federica Bortone, Francesca Andreetta, Fulvio Baggi, Pia Bernasconi, Carlo Antozzi, Paola Cavalcante & Renato Mantegazza. (2022) Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy. Biomedicines 10:6, pages 1360.
Crossref
Fiammetta Vanoli & Renato Mantegazza. (2022) Efgartigimod: A First-in-class Investigational Antibody Fragment for the Treatment of Generalized Myasthenia Gravis. US Neurology 18:2, pages 127.
Crossref
Y. Ozawa, A. Uzawa, M. Yasuda, Y. Kojima, F. Oda, K. Himuro, N. Kawaguchi & S. Kuwabara. (2020) Changes in serum complements and their regulators in generalized myasthenia gravis. European Journal of Neurology 28:1, pages 314-322.
Crossref
Ryuichi Nakamura, Tomohiro Makino, Takeshi Hanada, Maki Terakawa, Kazuhiro Nagahira, Jyoji Yamate, Hirokazu Shiraishi & Masakatsu Motomura. (2018) Heterogeneity of auto-antibodies against nAChR in myasthenic serum and their pathogenic roles in experimental autoimmune myasthenia gravis. Journal of Neuroimmunology 320, pages 64-75.
Crossref
Anna Rostedt Punga, Henry J. Kaminski & Jeffrey T. Guptill. 2018. Myasthenia Gravis and Related Disorders. Myasthenia Gravis and Related Disorders 319 333 .
Satoru Oji & Kyoichi Nomura. (2017) Immunoadsorption in neurological disorders. Transfusion and Apheresis Science 56:5, pages 671-676.
Crossref
Yulong Li, Min Yang, Rui Zhang, Wan Liu, Kuo Zhang, Wei Wen, Lang Yi, Qiaoxian Wang, Mingju Hao, Hui Yang, Jianmin Chang & Jinming Li. (2016) Evaluation of serum immunoglobulins concentrations and distributions in vitiligo patients. Immunologic Research 64:5-6, pages 1150-1156.
Crossref
Erdem Tüzün & Premkumar Christadoss. (2013) Complement associated pathogenic mechanisms in myasthenia gravis. Autoimmunity Reviews 12:9, pages 904-911.
Crossref
Weifan Yin, Windy Allman, Song Ouyang, Yi Li, Jing Li, Premkumar Christadoss & Huan Yang. (2013) The increased expression of CD21 on AchR specified B cells in patients with myasthenia gravis. Journal of Neuroimmunology 256:1-2, pages 49-54.
Crossref
Astrid Hjelholt, Thomas Carlsen, Bent Deleuran, Anne Grethe Jurik, Berit Schiøttz-Christensen, Gunna Christiansen & Svend Birkelund. (2013) Increased Levels of IgG Antibodies against Human HSP60 in Patients with Spondyloarthritis. PLoS ONE 8:2, pages e56210.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.